BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34097205)

  • 1. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments.
    Smajlović A; Haverić A; Alić A; Hadžić M; Smajlović A; Mujezinović I; Lojo-Kadrić N; Ramić J; Elez-Burnjaković N; Haverić S; Pojskić L
    Mol Biol Rep; 2021 May; 48(5):4295-4303. PubMed ID: 34097205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
    Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
    Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low systemic exposure and calcemic effect of calcipotriol/betamethasone ointment in rats with imiquimod-induced psoriasis-like dermatitis.
    Satake K; Amano T; Okamoto T
    Eur J Pharmacol; 2018 May; 826():31-38. PubMed ID: 29476878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
    Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
    Shi Q; He Q; Chen W; Long J; Zhang B
    J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways.
    Sangaraju R; Alavala S; Nalban N; Jerald MK; Sistla R
    Int Immunopharmacol; 2021 Jul; 96():107754. PubMed ID: 34162135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
    Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
    Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
    Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
    BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
    Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
    J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
    Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
    Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unconjugated bilirubin and its derivative ameliorate IMQ-induced psoriasis-like skin inflammation in mice by inhibiting MMP9 and MAPK pathway.
    Bharatha M; Nandana MB; Praveen R; Nayaka S; Velmurugan D; Vishwanath BS; Rajaiah R
    Int Immunopharmacol; 2024 Mar; 130():111679. PubMed ID: 38377853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P; Saka R; Kommineni N; Raza K; Khan W
    Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on ethanolic extract of sechiumedule fruitson imquimod-induced psoriasis like dermatitis in wistar rats.
    Sm F; Sarkar D; Samuel Kelechi M; AAl-Haidari R; N Al Busaidi H; Samman W; Alhaddad A; Ah Mostafa M
    Pak J Pharm Sci; 2022 Jul; 35(4):1083-1088. PubMed ID: 36008905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone attenuate level of myeloperoxidases and nitic oxide in psoriatic lesion: a proof-of-concept study in a imiquimod induced psoriasis model in rat.
    Chatterjee O; Sur D
    J Basic Clin Physiol Pharmacol; 2024 Jan; 35(1-2):45-52. PubMed ID: 38341859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells.
    Al-Harbi NO; Nadeem A; Ahmad SF; Bakheet SA; El-Sherbeeny AM; Ibrahim KE; Alzahrani KS; Al-Harbi MM; Mahmood HM; Alqahtani F; Attia SM; Alotaibi MR
    Eur J Pharmacol; 2020 Jun; 877():173088. PubMed ID: 32234429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycerol Improves Skin Lesion Development in the Imiquimod Mouse Model of Psoriasis: Experimental Confirmation of Anecdotal Reports from Patients with Psoriasis.
    Choudhary V; Kaddour-Djebbar I; Custer VE; Uaratanawong R; Chen X; Cohen E; Yang R; Ajebo E; Hossack S; Bollag WB
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist.
    Li Q; Liu W; Gao S; Mao Y; Xin Y
    BMC Immunol; 2021 Jan; 22(1):11. PubMed ID: 33509093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent.
    Parmar KM; Jagtap CS; Katare NT; Dhobi M; Prasad SK
    Indian J Pharmacol; 2021; 53(2):125-131. PubMed ID: 34100396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.